G&S Capital’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

G&S Capital’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-7	Closed	-$9K	–	227
2017 Q4	$9K	Buy	+7	New	+$3.29K	0.01%	174

Other funds holding AMPE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BCM

BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

G&S Capital's AMPE Position: Q1 2018 in Review

G&S Capital sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2018, closing a stake of 7 shares — an estimated $9K sold.

G&S Capital first reported a position in AMPE in Q4 2017 and held it in 1 quarter. The position peaked at $9K in Q4 2017. 71 funds tracked by Wall St. Rank hold AMPE as of Q1 2018.

G&S Capital reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2018 after selling out during the quarter.
G&S Capital sold 7 Ampio Pharmaceuticals Inc. shares in Q1 2018, an estimated $9K.
G&S Capital first reported a position in Ampio Pharmaceuticals Inc. in Q4 2017 and held it in 1 quarter.
G&S Capital's Ampio Pharmaceuticals Inc. position peaked at $9K in Q4 2017.
71 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2018.

Based on G&S Capital's 13F filing for Q1 2018, filed 25 Apr 2018.